Teva Pharmaceutical Industries Limited American Depositary Shares

TEVA 
(NYSE) 
 

Company Profile

Description
Headquartered in Israel, Teva Pharmaceutical is one of the world's largest generic pharmaceutical manufacturers. The company also develops and sells branded pharmaceuticals in central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about 55% of total revenue, with branded drug and distribution revenue making up the balance of sales. Prior to generic competition, Copaxone made up about half of Teva's branded drug segment, with about $4 billion in annual sales.
Key Stats
Website:
Headquarter country:
Employees: 0
Market Cap (at close ):
Fiscal Year Ends:

Stats



Price/Earnings
Forward Price/Earnings
Price/Free Cash Flow
Return of Assets
Return on Equity
Return on Invested Capital
20182017201620152014

Dividend


Dividend/Share
Ex. Dividend Date
Trailing Dividend Yield
Payout Ratio





Date Currency Amount

Income Statement DKK



Revenue
Total Revenue
Gross Profit
Gross Margin %
EBITDA
Net Income
Basic Earnings Per Share

Operating Expenses
Operating Income
Operation Margin %
20182017201620152014


Cash Flow DKK



Operating Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow
20182017201620152014


Balance Sheet DKK



Assets
Current Assets
Long Term Assets
Total Assets

Liabilities
Total Current Liabilities
Long Term Liabilities
Total Liabilities

Equity
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets
31-12-201831-12-201731-12-201631-12-201531-12-2014



Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
20. juni 2019 01:53:15
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190527.1 - EUROWEB2 - 2019-06-20 01:53:15 - 2019-06-20 01:53:15 - 1 - Website: OKAY